ARNA Profile
Arena Pharmaceuticals, Inc. (ARNA) is a biopharmaceutical company that is focused on the development and commercialization of novel drugs for the treatment of various diseases. The company's products are designed to target specific receptors in the body to address unmet medical needs.
Arena Pharmaceuticals' lead product is called Belviq (lorcaserin), which is an FDA-approved weight loss drug that targets the serotonin 2C receptor. The company also has a number of other product candidates in various stages of development for the treatment of pain, autoimmune diseases, and other conditions.
Arena Pharmaceuticals was founded in 1997 and is headquartered in San Diego, California. The company has partnerships with several major pharmaceutical companies, including Eisai Co., Ltd. and Axovant Sciences Ltd., for the development and commercialization of its products.
|
